Results 191 to 200 of about 99,522,423 (293)

The commercialization of “unvaccinated” blood: A cross‐sectional analysis of organizations marketing services based on donor COVID‐19 vaccination status

Transfusion, EarlyView.
Abstract Background Requests for blood from donors not vaccinated against COVID‐19 persist despite evidence that donor vaccination does not affect transfusion recipients. We characterized organizations marketing services based on donor vaccination status.
Jeremy W. Jacobs, Garrett S. Booth, Sheharyar Raza   +2 more
wiley   +1 more source

ACE2-like Catalytic Activity in Anti-SARS-CoV-2 Spike Protein Monoclonal Antibodies. [PDF]

Pathogens
Song Y, Mehl F, No T, Livingston L, Quintero-Barbosa JS, Hayashi J, Serrero G, Bortz PS, Wilson JM, Crowe JE, Ho DD, Yin MT, Tan J, Zeichner SL.   +13 more
europepmc   +1 more source

SARS‐CoV‐2 targets mitochondria, exacerbating COVID‐19 pneumonia

The Journal of Physiology, EarlyView.
Abstract figure legend Following entry into airway epithelial cells (AECs), SARS‐CoV‐2 releases its single‐stranded RNA into the cytoplasm, where it is translated into viral proteins. Several of these viral proteins localize to mitochondria and interact with key mitochondrial components.
Danchen Wu, Asish Dasgupta, Jaskaran Singh Hora, Kuang‐Hueih Chen, Arinjay Banerjee, Stephen L. Archer   +5 more
wiley   +1 more source

Correction: Pathogen effects on the brain: the case of SARS-CoV-2 spike protein and neuro COVID. [PDF]

Front Neurol
Theoharides TC, Papadopoulou P.
europepmc   +1 more source

Nontumor‐Specific mRNA Sensitization of Cold Tumors to Immune Checkpoint Blockade: Evidence, Bias, and Requirements for Translation

Advanced Oncology, Volume 1, Issue 1, December 2026.
Messenger RNA constructs encoding nontumor antigens are proposed to sensitize cold tumors to checkpoint blockade. Observational survival estimates favor vaccination but are heterogeneous, and bias‐focused analyses find no significant difference once time‐zero is aligned. Epitope spreading remains undemonstrated in humans. This review separates what the
Sarfaraz K. Niazi
wiley   +1 more source

Pathogen effects on the brain: the case of SARS-CoV-2 spike protein and neuro COVID. [PDF]

Front Neurol
Theoharides TC, Papadopoulou P.
europepmc   +1 more source

TEAM: A time‐enhanced attention‐based model for virus mutation prediction

Quantitative Biology, Volume 14, Issue 4, December 2026.
Abstract The evolution of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) during the coronavirus disease 2019 (COVID‐19) pandemic highlights the critical need for predicting virus mutations in order to stay ahead of infectious diseases. Here, we present the time‐enhanced attention‐based model (TEAM), which combines phylogenetic sampling ...
Jie Ji, Jie Hu, Tianwei Yu, Xiaodan Fan
wiley   +1 more source

Cryo-EM analysis of cooperative conformational changes in the SARS-CoV-2 spike protein trimer. [PDF]

IUCrJ
Wang Q, Cholak S, Woollard G, Subramaniam S, Dao Duc K.   +4 more
europepmc   +1 more source

Advanced Materials for Biologics Delivery to Brain Tumors

Advanced Materials, Volume 38, Issue 61, 2 November 2026.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng, Yuxue Cao, Maria Kavallaris, Taskeen Janjua, Amirali Popat   +4 more
wiley   +1 more source

Electrochemical Detection of SARS-CoV‑2 Spike Protein: A Fast and Effective Pathway to Pandemic Diagnostics. [PDF]

ACS Omega
Jašňáková N, Shepa J, Šišoláková I, Shepa I, Oriňaková R.   +4 more
europepmc   +1 more source